Whanin Pharm Co Ltd banner
W

Whanin Pharm Co Ltd
KRX:016580

Watchlist Manager
Whanin Pharm Co Ltd
KRX:016580
Watchlist
Price: 10 310 KRW -0.77% Market Closed
Market Cap: ₩157.4B

Whanin Pharm Co Ltd
Investor Relations

Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. The company is headquartered in Seoul, Seoul. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company’s products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The firm also involves in the real estate rental business.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Kwang-Sik Lee
Founder & Chairman
No Bio Available
Mr. Wonbum Lee
CEO & President
No Bio Available
Seung-Sik Lee
Senior Executive Director of Sales & Marketing Division
No Bio Available

Contacts

Address
SEOUL
Seoul
8-11F, Whanin Bldg., 11, Beobwon-ro 6-gil, Songpa-gu
Contacts
+8224053000
www.whanin.co.kr